共 176 条
[1]
Morone M(2017)Whole-body MRI: current applications in oncology Am J Roentgenol. American Roentgen Ray Society 209 W336-W349
[2]
Bali MA(2015)Role of magnetic resonance imaging in the Management of Patients with Multiple Myeloma: a consensus statement J Clin Oncol 33 657-664
[3]
Tunariu N(2017)Guidelines for the use of imaging in the management of patients with myeloma Br J Haematol Wiley 178 380-393
[4]
Messiou C(2019)Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS) Radiology. Radiological Society of North America 291 5-13
[5]
Blackledge M(2006)Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma Eur J Cancer 42 342-350
[6]
Grazioli L(2007)Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma Eur J Cancer 43 557-564
[7]
Dimopoulos MA(2013)Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients? Eur Radiol 23 3466-3476
[8]
Hillengass J(2014)Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis Skeletal Radiol Springer Nature 43 1503-1513
[9]
Usmani S(2017)METastasis reporting and data system for prostate Cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate Cancer Eur Urol Elsevier 71 81-92
[10]
Zamagni E(2017)The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer Eur J Cancer 77 109-116